1. Home
  2. CSL vs RDY Comparison

CSL vs RDY Comparison

Compare CSL & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carlisle Companies Incorporated

CSL

Carlisle Companies Incorporated

HOLD

Current Price

$346.39

Market Cap

13.4B

Sector

Industrials

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$13.70

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSL
RDY
Founded
1917
1984
Country
United States
India
Employees
N/A
N/A
Industry
Specialty Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4B
11.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CSL
RDY
Price
$346.39
$13.70
Analyst Decision
Buy
Strong Buy
Analyst Count
6
1
Target Price
$386.67
$16.90
AVG Volume (30 Days)
353.4K
1.5M
Earning Date
02-03-2026
01-20-2026
Dividend Yield
1.26%
0.52%
EPS Growth
N/A
5.58
EPS
17.56
0.76
Revenue
$5,015,100,000.00
$3,848,694,754.00
Revenue This Year
$0.99
$6.12
Revenue Next Year
$2.49
$2.58
P/E Ratio
$19.94
$17.77
Revenue Growth
0.14
11.09
52 Week Low
$293.43
$12.26
52 Week High
$435.92
$16.17

Technical Indicators

Market Signals
Indicator
CSL
RDY
Relative Strength Index (RSI) 51.72 51.80
Support Level $348.59 $12.82
Resistance Level $365.00 $13.85
Average True Range (ATR) 11.14 0.23
MACD -1.02 0.06
Stochastic Oscillator 51.27 77.54

Price Performance

Historical Comparison
CSL
RDY

About CSL Carlisle Companies Incorporated

Carlisle Companies Inc is a holding company. The company manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. The company is organized into two segments including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing underlayments, integrated air and vapor barriers, spray polyurethane foam and coating systems, and others. The majority of the company's revenue comes from the Carlisle Construction Materials segment, and more than half of the total revenue is earned in the United States.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: